Published in Rev Diabet Stud on May 10, 2014
Outpatient Management of Pediatric Type 1 Diabetes. J Pediatr Pharmacol Ther (2015) 0.80
Progress and challenges for treating Type 1 diabetes. J Autoimmun (2016) 0.75
A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation. Mol Ther (2017) 0.75
Progress and challenges of the bioartificial pancreas. Nano Converg (2016) 0.75
Induction of Nestin Early Expression as a Hallmark for Mesenchymal Stem Cells Expression of PDX-1 as a Pre-disposing Factor for Their Conversion into Insulin Producing Cells. Int J Stem Cells (2016) 0.75
Transplantable bioartificial pancreas devices: current status and future prospects. Langenbecks Arch Surg (2015) 0.75
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol (2008) 10.60
Diagnosis and classification of diabetes mellitus. Diabetes Care (2004) 8.66
Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86
Hydrogels for tissue engineering. Chem Rev (2001) 7.25
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Microencapsulated islets as bioartificial endocrine pancreas. Science (1980) 4.35
Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A (2009) 3.43
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev (2008) 2.63
Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery (1967) 2.49
Edmonton's islet success tough to duplicate elsewhere. Lancet (2003) 2.18
Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem (2008) 2.04
Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet (1994) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation (2010) 1.88
Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care (2006) 1.80
Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation (2007) 1.78
Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res (1995) 1.77
Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A (2003) 1.66
Implantable biohybrid artificial organs. Cell Transplant (1995) 1.65
2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud (2011) 1.57
Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules (2006) 1.50
Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care (2009) 1.48
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A (2001) 1.47
Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation (2006) 1.37
Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation (2006) 1.35
Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes (2001) 1.33
Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1. J Biomed Mater Res A (2010) 1.33
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant (2001) 1.26
Injectable biodegradable hydrogels. Macromol Biosci (2010) 1.24
Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev (2007) 1.24
Induction of cytokine production from human monocytes stimulated with alginate. J Immunother (1991) (1991) 1.23
Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc Natl Acad Sci U S A (2012) 1.23
The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol (1993) 1.18
Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med (2005) 1.15
Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation (1996) 1.14
Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett (2008) 1.14
Rat islet cell aggregates are superior to islets for transplantation in microcapsules. Diabetologia (2010) 1.14
Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes (1999) 1.13
Alginate-based encapsulation of cells: past, present, and future. Curr Diab Rep (2007) 1.11
Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats. Am J Physiol Endocrinol Metab (2010) 1.09
The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res (2001) 1.09
Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation (2009) 1.09
Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care (2011) 1.08
Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc (2005) 1.07
Clinical and experimental experience with pancreaticocystostomy for exocrine pancreatic drainage in pancreas transplantation. Transplant Proc (1984) 1.07
Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci U S A (1993) 1.07
Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science (1991) 1.06
Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS One (2011) 1.05
Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. Rev Diabet Stud (2010) 1.03
Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation (2005) 1.02
Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials (2007) 1.02
Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia (1997) 1.01
Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation (2005) 0.99
Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99
Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes (1994) 0.99
Islet transplantation and encapsulation: an update on recent developments. Rev Diabet Stud (2011) 0.98
Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med (2012) 0.98
Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem (2009) 0.98
Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication. Tissue Eng (2007) 0.97
Rapamycin impairs proliferation of transplanted islet β cells. Transplantation (2011) 0.97
Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater (2011) 0.97
Pancreas and islet transplantation. II. Clinical trials. Diabetologia (1981) 0.96
Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett (2006) 0.96
In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A (2010) 0.96
Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Diabetologia (2011) 0.96
Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model. Transplantation (2008) 0.95
Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant (1997) 0.94
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc (2006) 0.93
Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. Transplantation (1996) 0.93
Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Transplantation (1998) 0.93
Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes (1991) 0.93
Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng (1991) 0.93
A membrane-mimetic barrier for islet encapsulation. Transplant Proc (2004) 0.93
The TheraCyte™ device protects against islet allograft rejection in immunized hosts. Cell Transplant (2012) 0.93
Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transplant (2004) 0.92
Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials (2004) 0.92
The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis (2007) 0.92
Quadrupole magnetic sorting of porcine islets of Langerhans. Tissue Eng Part C Methods (2009) 0.92
Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation (1999) 0.91
The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells. Biomaterials (2009) 0.91
Nanomedicine and its potential in diabetes research and practice. Diabetes Metab Res Rev (2008) 0.91
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum Gene Ther (2000) 0.91
Clinical islet transplant: current and future directions towards tolerance. Immunol Rev (2003) 0.90
Selective beta-cell differentiation of dissociated embryonic pancreatic precursor cells cultured in synthetic polyethylene glycol hydrogels. Tissue Eng Part A (2009) 0.89
Microencapsulation of pancreatic islet cells: a bioartificial endocrine pancreas. Methods Enzymol (1988) 0.89
Islet transplantation: lessons learned since the Edmonton breakthrough. Transplant Proc (2010) 0.89
Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit Rev Biomed Eng (2011) 0.88
Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel. Biomaterials (2012) 0.88
The use of biomaterials in islet transplantation. Curr Diab Rep (2011) 0.88
Optimization of monomethoxy-polyethylene glycol grafting on the pancreatic islet capsules. J Biomed Mater Res (2002) 0.86
Preclinical development of the Islet Sheet. Ann N Y Acad Sci (2001) 0.86
Effect of micro- and macroencapsulation on oxygen consumption by pancreatic islets. Cell Transplant (2009) 0.86
A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann N Y Acad Sci (2001) 0.86
Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation (1997) 0.86
Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation (2011) 0.86
Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study. Cell Transplant (2003) 0.85